New drug combo shows promise in shrinking tough breast cancer before surgery
Disease control
Recruiting now
This study tests whether adding the drug darolutamide to standard chemotherapy and immunotherapy before surgery can shrink tumors more effectively in people with early-stage androgen receptor positive triple-negative breast cancer. About 51 participants will receive either standa…
Phase: PHASE2 • Sponsor: Vandana Abramson • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC